Samsung-backed AI chip firm Rebellions raises $400 million ahead of IPO
Rebellions' chips are focused on AI inferencing, putting it in competition with Nvidia as well as other startups from Groq to Cerebras.
Samsung-backed AI chip firm Rebellions raises $400 million ahead of IPO
Rebellions' chips are focused on AI inferencing, putting it in competition with Nvidia as well as other startups from Groq to Cerebras.
FilterCNBC
Clustered coverageCNBC
Coverage timeline1
Coverage timeline
Coverage timeline
Ranked reports inside the event cluster. Open any publisher link to read the original coverage.
Related events
Related events
Nearby clusters pulled from title, summary, and keyword similarity in PostgreSQL.
1 report1 sourceSimilarity 0.38
Mistral secures $830 million in debt financing to fund AI data center
Mistral is one of the few European startups building foundational AI models.
CNBC
1 report1 sourceSimilarity 0.23
Iran 30 days into internet blackout, isolating millions amid war
The domestic intranet remains operational with local messaging apps, banking platforms and other services.
The Straits Times
1 report1 sourceSimilarity 0.23
Exhausted Palestinians struggle to put lives back together as world’s gaze fixes on Iran
Five months after a ceasefire was announced in Gaza, airstrikes are still killing civilians and the humanitarian situation remains dire There is little left that connects Palestinians in Gaza with their prewar…
The Guardian
1 report1 sourceSimilarity 0.22
Apocalyptic scenes from Australia ahead of cyclone make worldwide news
Cyclone Narelle turned the sky over parts of Western Australia's north into an ominous red, sparking headlines across the globe.
ABC Australia
1 report1 sourceSimilarity 0.22
Meta's court losses spell potential trouble for AI research, consumer safety
Meta's two courtroom defeats centered on different cases but both involved allegations that the company knew about its products' harms.
CNBC
1 report1 sourceSimilarity 0.22
Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market
U.S. pharmaceutical giant Eli Lilly will give Hong Kong-listed Insilico $115 million upfront to bring some of its AI-discovered drugs to the global market.
CNBC